Company intelligence / Profile preview

Kendall Capital Partners

Boston, Massachusetts, United Stateskcpventures.com ↗

Ownership: Private
Development stage: Other

Overview

Kendall Capital Partners is a Boston-based venture capital firm specializing in early-stage investments in biotech and healthcare startups. They have led funding rounds for innovative companies like Rejuvenate Bio (gene therapy for aging) and Eyenuk (AI-powered eye disease diagnostics). Their portfolio spans gene therapies for age-related diseases, tissue engineering platforms, drug delivery technologies, and commercial-stage diagnostic solutions

Therapeutic areas: Metabolic DisordersOphthalmology
Modalities: Gene therapySmall moleculeAI diagnosticsDrug delivery platform
Industry: Investors

Partnerships

VCapitalKdT VenturesDigitalis Ventures

Beyond the preview

Go deeper on Kendall Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kendall Capital Partners.

Explore the full profile